Pfizer and BioNTech achieve world first authorization for COVID-19 vaccine

Pfizer Inc. and BioNTech SE have announced that the Medicines & Healthcare Products Regulatory Agency (MHR...

December 2, 2020 | Wednesday | News
BioNTech-Pfizer apply CMA for COVID-19 Vaccine to the EMA

BioNTech SE and Pfizer Inc. on 30 Nov 2020 have submitted a formal Application for Conditional Marketing ...

December 2, 2020 | Wednesday | News
Korea contributes $3M to CEPI to advance vaccine development

The government of the Republic of Korea (ROK) has decided to contribute $3 million in 2020 for the first time to the Coa...

November 30, 2020 | Monday | News
AstraZeneca vaccine meet primary efficacy endpoint in preventing COVID-19

Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vacci...

November 27, 2020 | Friday | News
Korea inks MoU with Ecuador for global health R&D

The International Vaccine Institute (IVI) and Ministry of Foreign Affairs and Human Mobility of Ecuador exchanged a memo...

November 26, 2020 | Thursday | News
Sputnik V vaccine single dose to be less than $10 at international markets

The cost of one dose of the Sputnik V vaccine for international markets will be less than $10. Sputnik V is a ...

November 25, 2020 | Wednesday | News
Korea pushes vaccine R&D for global health

The International Vaccine Institute (IVI) and the Vaccine Innovative Technology ALliance Korea (VITAL-Korea) agreed to j...

November 24, 2020 | Tuesday | News
Hester Biosciences Nepal unveils live thermo-tolerant PPR vaccine

Hester Nepal recently got the regulatory approval and marketing authorisation from Department of Drug Administration (DD...

November 23, 2020 | Monday | News
CEPI's collaborative task force to assess COVID-19 vaccines on emerging viral strains

To rapidly monitor the emergence of new COVID-19 viral strains and evaluate their impact on vaccine candidates in develo...

November 23, 2020 | Monday | News
Pfizer, BioNTech demonstrate 95% efficacy of COVID-19 vaccine

Pfizer Inc. and BioNTech have announced that, after conducting the final efficacy analysis in their ongoing Ph...

November 23, 2020 | Monday | News
Cytiva supports Clover Biopharma to scale up output of COVID-19 vaccine candidate

US-based Cytiva, a global life sciences leader, is supporting Shanghai-based Clover Biopharmaceuticals, a global clinica...

November 17, 2020 | Tuesday | News
Australia unveils plans for new flu vaccine facility

The Australian government has announced that the largest flu vaccine manufacturing plant in the southern hemisphere will...

November 16, 2020 | Monday | News
South Korea to host production of 150M Sputnik V doses for global distribution

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and GL Rapha, one of the leading South ...

November 13, 2020 | Friday | News
Arcturus Therapeutics receives $220M from Singapore for COVID-19 vaccine development

Arcturus Therapeutics Holdings Inc., based in the US, has announced positive interim clinical study results from its ong...

November 12, 2020 | Thursday | News
COVID-19 vaccine candidate by Pfizer, BioNTech shows more than 90% effectivity

Pfizer Inc. and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV...

November 10, 2020 | Tuesday | News
Australia secures further 50M doses of COVID-19 vaccine

Two more COVID-19 vaccines have been secured for the Australian population under new agreements, bringing the Australian...

November 5, 2020 | Thursday | News
Australia reports highest childhood vaccination rates in 2020

On 1 Nov 2020, Australia reported the highest recorded childhood vaccination, with new figures showing four quarters of ...

November 2, 2020 | Monday | News
Takeda expands COVID-19 vaccine supply in Japan

Takeda Pharmaceutical has announced that it will import and distribute 50 million doses of Moderna’s COVID-19...

October 30, 2020 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls